country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Tamoxifen in the treatment of breast cancer

N Engl J Med. 1998 Nov 26;339(22):1609-18. doi: 10.1056/NEJM199811263392207.

C K Osborne ¹

Affiliations

PMID: 9828250 DOI: 10.1056/NEJM199811263392207

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-13757A

Tamoxifen

99.96%, Estrogen Receptor Modulator

target: Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Research Areas: Neurological Disease; Metabolic Disease; Inflammation/Immunology; Infection; Cancer
HY-13757

Tamoxifen Citrate

99.88%, Estrogen Receptor Modulator

target: Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Research Areas: Neurological Disease; Inflammation/Immunology; Infection; Cancer
HY-13757AR

Tamoxifen (Standard)

99.94%, Estrogen Receptor Modulator

target: Reference Standards; Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Research Areas: Endocrinology; Cancer
HY-13757AS

Tamoxifen-d₅

99.77%, Stable Isotope

target: Isotope-Labeled Compounds; Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Research Areas: Cancer
HY-13757S

Tamoxifen-d₃ hydrochloride

98.99%, Stable Isotope

target: Autophagy; HSP; Estrogen Receptor/ERR; Apoptosis; Isotope-Labeled Compounds

Research Areas: Cancer
HY-13757AS1

Tamoxifen-d₃

Stable Isotope

target: Isotope-Labeled Compounds; Estrogen Receptor/ERR; Apoptosis; Autophagy; HSP

Research Areas: Cancer
HY-13757R

Tamoxifen Citrate (Standard)

Estrogen Receptor Modulator

target: Reference Standards; Estrogen Receptor/ERR; HSP; Autophagy; Apoptosis

Research Areas: Cancer